In 2024, Genscript Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Genscript Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 |
|---|---|---|
Total Scope 1 | 39,376.8a | 48,821.78a |
Total Scope 2 | ||
Market-Based | 114,034.82a | 83,758.36a |
Location-Based | 112,287.37a | 83,758.36a |
Total Scope 3 | 387,028a | 314,658.76a |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 66.2367a | 87.1071a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Genscript Biotech amounted to 151,664.17 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Genscript Biotech increased by 14.39%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2024, the total Scope 1 emissions of Genscript Biotech were 39,376.8 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2023), Genscript Biotech's Scope 1 emissions decreased by 19.35%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2024, Genscript Biotech reported Scope 2 greenhouse gas (GHG) emissions of 114,034.82 tCO₂e using the market-based method and 112,287.37 tCO₂e using the location-based method.a
Compared to the previous year (2023), Genscript Biotech's Scope 2 emissions (Location-Based) rose by 34.06% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
In 2024, Genscript Biotech reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2024, Genscript Biotech reported 387,028 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Genscript Biotech includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Genscript Biotech reported total Scope 3 emissions of 387,028 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2023), Genscript Biotech's Scope 3 emissions increased by 23%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2024, Genscript Biotech reported Scope 1 greenhouse gas (GHG) emissions of 39,376.8 tCO₂e and total revenues of USD 594 millions. This translates into an emissions intensity of 66.24 tCO₂e per millions USD.a
In 2024, Genscript Biotech reported a Scope 1 emissions intensity of 66.24 tCO₂e per millions USD. Compared to the peer group median of 10.66, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, Genscript Biotech ranked 22 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Genscript Biotech among the least efficient performers, with one of the highest emissions intensities in its sector.a
In 2024, Genscript Biotech reported a total carbon footprint of 538,692.17 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 20.45% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Genscript Biotech's total carbon footprint was Scope 3 emissions, accounting for 71.85% of the company's total carbon footprint, followed by Scope 2 emissions at 20.84%.a